No Data
No Data
Ipsen Expands Collaboration Agreement With Exelixis
IPSEN - Buy-back Programme - Art 5 of MAR - Week 23 - 2024
FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
Ipsen SA (OTC:IPSEF) (OTC:IPSEY) announced Monday that the U.S. Food and Drug Administration (FDA) had granted accelerated approval for Iqirvo (elafibranor) 80 mg tablets to treat primary biliary chol
Ipsen Gains Accelerated Approval for Elafibranor for Rare Liver Disease
GENFIT Says Iqirvo Is First-ever Drug Developed In-house By Company To Achieve FDA Approval; Expects To Receive Milestone Payments From Ipsen
GENFIT is eligible to receive a €48.7 million milestone payment from Ipsen upon the first commercial sale of Iqirvo in the U.S., as well as tiered double-digit royalties of up to 20%.Ipsen's Iqirvo (e
Ipsen and Marengo Therapeutics Announce Second Strategic Partnership
No Data
SanjBot : nothing like a few gallstones to make you feel alive.